Core Viewpoint - The group opposes the proposal to increase capital requirements, arguing that it would negatively impact operations and burden the economy [1] Group Summary - The group believes that the proposed increase in capital requirements would harm its operational capabilities [1] - The group asserts that the plan would impose additional economic burdens on the country [1]

Core Viewpoint - Gilead Sciences, Inc. (NASDAQ:GILD) is considered one of the most undervalued blue chip stocks currently available for investment [1] Analyst Upgrades - UBS analyst Michael Yee upgraded Gilead's stock from 'Neutral' to 'Buy' and raised the price target from $112 to $145, citing strong expectations for HIV pre-exposure prophylaxis sales from Yeztugo [2] - Citi analyst Geoff Meacham also raised the price target from $135 to $140 while maintaining a 'Buy' rating, reflecting growing confidence in Gilead's outlook [3] Strategic Developments - Gilead exercised its option to exclusively license Assembly Biosciences' long-acting HSV helicase-primase inhibitor programs, ABI-1179 and ABI-5366, which aims to expand its antiviral pipeline into areas with significant unmet needs [4] - The licensing deal is supported by positive Phase 1b data and the potential for once-weekly oral dosing, indicating a strategic evolution towards more durable, growth-oriented demand drivers in the antiviral sector [4] Company Focus - Gilead Sciences, Inc. is a biopharmaceutical company that specializes in the development and commercialization of innovative medicines across various therapeutic areas, including HIV, liver disease, oncology, hematology, and inflammatory conditions [5]

Core Viewpoint - UBS has rejected government proposals aimed at strengthening regulations for the bank following the collapse of Credit Suisse, arguing that such measures would render Switzerland uncompetitive and advocating for alternative solutions [1] Group 1 - UBS's rejection of regulatory proposals is based on the belief that they would negatively impact Switzerland's competitiveness in the banking sector [1] - The bank is advocating for different approaches to address the issues raised by the Credit Suisse collapse rather than implementing stricter regulations [1]

Core Viewpoint - Lennar Corporation (NYSE:LEN) has faced challenges in the homebuilding sector, with its shares remaining flat over the year but showing a 15% increase year-to-date. The company is dealing with inventory clearance issues, which have led to downgrades from financial firms [2][3]. Group 1: Company Performance - Lennar's shares are flat over the past year but have increased by 15% year-to-date [2]. - The company sold a stake in its multifamily business to TPG, which also committed an additional $1 billion [2]. - Citizens Financial downgraded Lennar's shares to Market Perform from Market Outperform following its fiscal fourth quarter earnings report, citing inventory clearance concerns [2]. Group 2: Market Conditions - UBS downgraded Lennar's rating to Neutral from Buy, linking the downgrade to high interest rates affecting the housing market [3]. - Jim Cramer highlighted that the high interest rates are a significant barrier for starter homes, indicating a lack of traction in the housing market [3].

Core Viewpoint - Broadcom Inc. (NASDAQ:AVGO) has seen a significant share price increase of 49% over the past year, driven by its strong position in the AI chip market and positive analyst sentiment [2]. Company Performance - Broadcom's shares have gained 49% over the past year, benefiting from AI-generated attention due to its custom chip design capabilities [2]. - Goldman Sachs added Broadcom to its US Conviction List with a price target of $450 and a Buy rating on January 5th, citing the company's strong position in the enterprise silicon market [2]. - UBS raised Broadcom's price target to $475 from $472 while maintaining a Buy rating in December [2]. Executive Leadership - Jim Cramer praised Broadcom's CEO, Hock Tan, as one of the best executives in the technology industry, indicating strong leadership at the company [2]. Market Trends - Cramer highlighted a shift where hardware stocks, like Broadcom, are outperforming software stocks, suggesting a changing landscape in the tech industry [3].

Company Overview - Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels [1] - The company is headquartered in Indianapolis, Indiana and operates twelve facilities throughout North America [1] Upcoming Events - Calumet plans to attend the UBS Global Energy & Utilities Winter Conference on January 13, 2026 [2] - The company will hold one-on-one investor meetings throughout the day of the conference [2]

Group 1 - Hong Kong-based CK Hutchison has selected Goldman Sachs and UBS Group AG to assist with the planned initial public offering (IPO) of its subsidiary A.S. Watson Group [1] - The IPO is part of CK Hutchison's strategy to enhance its capital structure and unlock value from its investments [1] - A.S. Watson Group is a leading health and beauty retailer, which could attract significant investor interest due to its market position [1]

Core Insights - UBS Global Wealth Management US announced that Hollenbaugh, Rukeyser, Safro & Williams has been named to Forbes America's Top Private Wealth Management Teams list for 2025, ranking 4 nationally [1] - This ranking makes it the highest ranked UBS team on the list and marks the third consecutive year that the team has received this recognition [1] - Hollenbaugh, Rukeyser, Safro & Williams consists of a 13-person team [1]

Core Insights - Copper prices are surging due to tighter supplies and a risk-on sentiment in broader markets [1] - Concerns over potential US tariffs have led to increased shipments to the US, impacting global supply dynamics [2] - A strike at the Mantoverde mine in Chile highlights risks to shipments amid rising global demand [2] Supply and Demand Dynamics - Copper futures in London rallied by up to 3.5%, nearing the previous peak of just below $13,000 per ton [2] - The global refined copper market was estimated to be in surplus in 2025, but US tariffs distorted metal and inventory flows, increasing US imports [5] - Analysts predict a global copper shortage of over 100,000 tons in 2026 due to overall supply shortfalls and regional dislocation caused by tariffs [7] Market Trends - The cash-to-three month spread in London remains in backwardation, indicating near-term tightness in the copper market [6] - Copper prices rose by 3% to $12,844 per ton, while aluminum also saw a rise of 1.8% to $3,069 per ton, reflecting a tightening supply outlook [8]

Group 1 - Ameren Corporation (NYSE:AEE) is recognized as one of the 8 most profitable utility stocks to buy currently [1] - UBS maintains a buy rating on Ameren Corporation while reducing its price target from $121 to $115 [2] - Morgan Stanley keeps an Equal Weight rating on Ameren Corporation and lowers its price target from $108 to $103, highlighting data centers as a key growth driver for utility performance in 2026 [2] Group 2 - Ameren Corporation revised its long-term EPS growth guidance to a compound annual rate of 6% to 8% from 2025 through 2029, with a 2025 EPS estimate between $4.90 and $5.10 per share [3] - The projected EPS for 2026 is between $5.25 and $5.45 [3] - Ameren operates as a regulated utility in Illinois and Missouri, with improved regulations in Missouri creating substantial investment opportunities, while management has effectively navigated regulatory challenges in Illinois [4] Group 3 - The stock of Ameren Corporation has increased by 12.21% year-to-date as of December 31, 2025 [4]